End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.54 RUB | +1.43% | -.--% | -.--% |
26/04 | Artgen Biotech PJSC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Artgen Biotech PJSC Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Sales per Business
RUB in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Neovasculgen
27.5
%
| 186 | 15.8 % | 313 | 27.5 % | +68.21% |
Genetiko
25.1
%
| 384 | 32.5 % | 285 | 25.1 % | -25.58% |
Gemabank
22.6
%
| 267 | 22.6 % | 257 | 22.6 % | -3.70% |
Reprobank
17.8
%
| 283 | 24.0 % | 202 | 17.8 % | -28.67% |
SPRS-Therapy
4.8
%
| 54 | 4.6 % | 54 | 4.8 % | -0.33% |
Other Areas and Unallocated Business Expenses
2.2
%
| 7 | 0.6 % | 25 | 2.2 % | +285.36% |
Sales per region
RUB in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Russia
100.0
%
| 1,181 | 100.0 % | 1,137 | 100.0 % | -3.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 54 | 27/03/27 | |
Director of Finance/CFO | - | - | |
Chief Administrative Officer | - | - | |
Roman Deev
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/10/01 |
Director/Board Member | - | - | |
Sergey Kiselev
BRD | Director/Board Member | 66 | 28/07/28 |
Director/Board Member | 65 | 05/04/05 | |
Investor Relations Contact | 56 | 29/10/29 | |
Comptroller/Controller/Auditor | - | - | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrey Isaev
BRD | Director/Board Member | 53 | 28/07/28 |
Director/Board Member | 65 | 05/04/05 | |
Sergey Kiselev
BRD | Director/Board Member | 66 | 28/07/28 |
Roman Deev
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/10/01 |
Director/Board Member | 43 | 01/11/01 | |
Founder | 54 | 27/03/27 | |
Director/Board Member | - | - | |
Boris Maizel
BRD | Director/Board Member | - | 04/16/04 |
Director/Board Member | - | 04/16/04 | |
Alexey Primak
BRD | Director/Board Member | - | 29/23/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 92,645,451 | 21,091,099 ( 22.77 %) | 18,420,395 ( 19.88 %) | 22.77 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-.--% | 47.1M | |
+14.24% | 81.84B | |
-30.27% | 70.69B | |
+9.37% | 29.03B | |
-11.90% | 16.97B | |
-0.36% | 16.83B | |
-1.17% | 15.28B | |
+5.90% | 12.41B | |
+36.47% | 12.26B | |
-4.20% | 11.86B |
- Stock Market
- Equities
- ISKJ Stock
- Company Human Stem Cells Institute